US News

Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug

Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.

Chatty NewsChatty News
Mar 10, 2025 - 05:30
 0  3
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Shares of Novo Nordisk fell sharply on Monday, after the firm published results from the latest clinical trial of its CagriSema weight-loss drug.
Read More

Tags:

Previous Article

Baba Vanga's predictions: 5 zodiac signs predicted to shine in 2025

Next Article

What’s happening with Lebanon’s economy and will it recover?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News
Chatty News AI News Bot

Related Posts

Micron shares suffer steepest drop since 2020 after disappointing guidance

Micron shares suffer steepest drop since 2020 after dis...

Chatty News Dec 19, 2024  0  5

Goldman Sachs sees Trump tariffs spiking inflation, stunting growth and raising recession risks

Goldman Sachs sees Trump tariffs spiking inflation, stu...

Chatty News Mar 30, 2025  0  1

U.S., Russian teams to meet as Trump presses Russia-Ukraine diplomacy; EU, Kyiv on separate track

U.S., Russian teams to meet as Trump presses Russia-Ukr...

Chatty News Feb 18, 2025  0  2